These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26455771)

  • 1. Marmesin is a novel angiogenesis inhibitor: Regulatory effect and molecular mechanism on endothelial cell fate and angiogenesis.
    Kim JH; Kim JK; Ahn EK; Ko HJ; Cho YR; Lee CH; Kim YK; Bae GU; Oh JS; Seo DW
    Cancer Lett; 2015 Dec; 369(2):323-30. PubMed ID: 26455771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marmesin-mediated suppression of VEGF/VEGFR and integrin β1 expression: Its implication in non-small cell lung cancer cell responses and tumor angiogenesis.
    Kim JH; Kim MS; Lee BH; Kim JK; Ahn EK; Ko HJ; Cho YR; Lee SJ; Bae GU; Kim YK; Oh JS; Seo DW
    Oncol Rep; 2017 Jan; 37(1):91-97. PubMed ID: 27878269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broussonin A- and B-mediated inhibition of angiogenesis by blockade of VEGFR-2 signalling pathways and integrin β1 expression.
    Kim JH; Kim S; Han S; Ahn EK; Cho YR; Jeong W; Kim SJ; Bae GU; Oh JS; Seo DW
    J Cell Mol Med; 2022 Feb; 26(4):1194-1205. PubMed ID: 34994065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6K‑dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation.
    Cho YR; Kim JH; Kim JK; Ahn EK; Ko HJ; In JK; Lee SJ; Bae GU; Kim YK; Oh JS; Seo DW
    Oncol Rep; 2014 Oct; 32(4):1531-6. PubMed ID: 25109823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.
    Li M; Wu S; Liu Z; Zhang W; Xu J; Wang Y; Liu J; Zhang D; Tian H; Li Y; Ye W
    Biochem Pharmacol; 2012 May; 83(9):1251-60. PubMed ID: 22305746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
    Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coptis japonica Makino extract suppresses angiogenesis through regulation of cell cycle-related proteins.
    Kim SH; Kim EC; Kim WJ; Lee MH; Kim SY; Kim TJ
    Biosci Biotechnol Biochem; 2016 Jun; 80(6):1095-106. PubMed ID: 26924430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling.
    Huang S; Yang N; Liu Y; Hu L; Zhao J; Gao J; Li Y; Li C; Zhang X; Huang T
    Nutr Res; 2012 Jul; 32(7):530-6. PubMed ID: 22901561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
    Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
    Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest.
    Ling Y; Chen Y; Chen P; Hui H; Song X; Lu Z; Li C; Lu N; Guo Q
    Exp Biol Med (Maywood); 2011 Jul; 236(7):851-8. PubMed ID: 21659383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.
    Kalkunte S; Brard L; Granai CO; Swamy N
    Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.
    Bräutigam J; Bischoff I; Schürmann C; Buchmann G; Epah J; Fuchs S; Heiss E; Brandes RP; Fürst R
    J Mol Cell Cardiol; 2019 Oct; 135():97-108. PubMed ID: 31381906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.